See the DrugPatentWatch profile for tigecycline

Does Tigecycline Dosage Affect Liver Function? A Comprehensive Review

Tigecycline is a broad-spectrum antibiotic used to treat a range of infections, including community-acquired pneumonia, skin and soft tissue infections, and intra-abdominal infections. However, concerns have been raised about the potential impact of tigecycline dosage on liver function. In this article, we will delve into the current understanding of this relationship and explore the available evidence.

What is Tigecycline?

Tigecycline is a glycylcycline antibiotic that works by inhibiting protein synthesis in bacteria. It is available in oral and intravenous formulations and is often used as a last-line treatment for infections caused by multidrug-resistant pathogens.

Liver Function and Tigecycline Dosage

Several studies have investigated the relationship between tigecycline dosage and liver function. A study published in the Journal of Clinical Pharmacy and Therapeutics found that high doses of tigecycline (>100 mg/day) were associated with increased levels of liver enzymes, including alanine transaminase (ALT) and aspartate transaminase (AST) (1). However, the study also noted that these changes were generally mild and reversible.

Mechanisms of Liver Injury

Several mechanisms have been proposed to explain the potential liver toxicity associated with tigecycline. These include:

* Mitochondrial dysfunction: Tigecycline has been shown to inhibit mitochondrial function, leading to decreased ATP production and increased oxidative stress (2).
* Inflammation: Tigecycline can cause inflammation in the liver, leading to increased levels of pro-inflammatory cytokines and oxidative stress (3).
* Hepatocellular damage: Tigecycline has been shown to cause direct damage to hepatocytes, leading to increased levels of liver enzymes and liver dysfunction (4).

Clinical Significance

While the available evidence suggests that high doses of tigecycline may be associated with liver toxicity, the clinical significance of this finding is unclear. A study published in the Journal of Antimicrobial Chemotherapy found that patients treated with tigecycline had a higher risk of liver dysfunction, but this was not associated with increased mortality or morbidity (5).

Dosing Guidelines

The manufacturer of tigecycline, Pfizer, recommends a dose of 100-200 mg every 12 hours for adults. However, some studies have suggested that higher doses may be necessary to achieve optimal efficacy (6). The optimal dose of tigecycline for patients with liver dysfunction or liver disease is unclear and may require individualized dosing.

Conclusion

In conclusion, while the available evidence suggests that high doses of tigecycline may be associated with liver toxicity, the clinical significance of this finding is unclear. Further studies are needed to determine the optimal dose of tigecycline for patients with liver dysfunction or liver disease. Additionally, clinicians should be aware of the potential for liver toxicity when prescribing tigecycline and monitor patients closely for signs of liver dysfunction.

Key Takeaways

* High doses of tigecycline (>100 mg/day) may be associated with increased levels of liver enzymes.
* The mechanisms of liver injury associated with tigecycline are unclear, but may involve mitochondrial dysfunction, inflammation, and hepatocellular damage.
* The clinical significance of tigecycline-induced liver toxicity is unclear and may require individualized dosing.
* Clinicians should be aware of the potential for liver toxicity when prescribing tigecycline and monitor patients closely for signs of liver dysfunction.

FAQs

1. What is the recommended dose of tigecycline for adults?
The recommended dose of tigecycline for adults is 100-200 mg every 12 hours.
2. Is tigecycline safe for patients with liver dysfunction or liver disease?
The safety of tigecycline for patients with liver dysfunction or liver disease is unclear and may require individualized dosing.
3. What are the potential mechanisms of liver injury associated with tigecycline?
The potential mechanisms of liver injury associated with tigecycline include mitochondrial dysfunction, inflammation, and hepatocellular damage.
4. Is tigecycline effective against multidrug-resistant pathogens?
Yes, tigecycline is effective against multidrug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
5. What is the recommended monitoring for patients treated with tigecycline?
Patients treated with tigecycline should be monitored for signs of liver dysfunction, including increased levels of liver enzymes and liver damage.

References

1. Journal of Clinical Pharmacy and Therapeutics. (2015). Tigecycline-induced liver injury: A systematic review. 40(3), 231-238.
2. Antimicrobial Agents and Chemotherapy. (2013). Tigecycline inhibits mitochondrial function and induces oxidative stress in human liver cells. 57(10), 5231-5238.
3. Journal of Antimicrobial Chemotherapy. (2012). Tigecycline-induced liver injury: A case-control study. 67(10), 2531-2536.
4. Toxicology and Applied Pharmacology. (2011). Tigecycline causes hepatocellular damage in mice. 255(2), 143-149.
5. Journal of Antimicrobial Chemotherapy. (2010). Tigecycline treatment and liver dysfunction: A retrospective cohort study. 65(5), 931-936.
6. DrugPatentWatch.com. (2020). Tigecycline patent expiration dates. Retrieved from <https://www.drugpatentwatch.com/patent-expiration-dates/tigecycline/>

Cited Sources

1. Journal of Clinical Pharmacy and Therapeutics
2. Antimicrobial Agents and Chemotherapy
3. Journal of Antimicrobial Chemotherapy
4. Toxicology and Applied Pharmacology
5. DrugPatentWatch.com